SCHEMBL13564950

SCHEMBL13564950

CC(C)S(=O)(=O)NCCCCCNc1ccc(N2C[C@@H](C)O[C@@H](C)C2)c(F)c1F

nearest known ligand 0.39

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
GRIA1 P42261 3/20 0.39
NPY5R Q15761 8/20 0.36
TRPV1 Q8NER1 1/20 0.34
BRD4 O60885 1/20 0.33
KDM4E B2RXH2 2/20 0.33
HTT P42858 1/20 0.33
LMNA P02545 1/20 0.32
PDE3B Q13370 1/20 0.32
PDE3A Q14432 1/20 0.32
KCNH2 Q12809 1/20 0.32
HTR1A P08908 1/20 0.32
USP30 Q70CQ3 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13565977 0.92 GRIA1 (0.37) GRIA1NPY5RTRPV1BRD4KDM4E
SCHEMBL17090277 0.92 GRIA1 (0.37) GRIA1NPY5RTRPV1BRD4KDM4E
SCHEMBL13565167 0.90 GRIA1 (0.36) GRIA1NPY5RTRPV1BRD4KDM4E
SCHEMBL17090279 0.90 GRIA1 (0.36) GRIA1NPY5RTRPV1BRD4KDM4E
SCHEMBL17090541 0.87 NPY5R (0.42) GRIA1NPY5RTRPV1BRD4HTR1A
SCHEMBL13564951 0.87 NPY5R (0.42) GRIA1NPY5RTRPV1BRD4HTR1A
SCHEMBL17090058 0.87 GRIA1 (0.40) GRIA1NPY5RBRD4KDM4ELMNA
SCHEMBL13564973 0.87 GRIA1 (0.40) GRIA1NPY5RBRD4KDM4ELMNA
SCHEMBL13565166 0.87 GRIA1 (0.40) GRIA1NPY5RBRD4KDM4ELMNA
SCHEMBL10115300 0.85 KMT2A (0.38) TRPV1KDM4ELMNAHTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9139518-B2 Amine derivative having NPY Y5 receptor antagonistic activity SHIONOGI & CO., LTD. (JP) 2015-09-22 US disclosed
US-8299265-B2 Amine derivatives having NPY Y5 receptor antagonistic activity and the uses thereof SHIONOGI & CO., LTD. (JP) 2012-10-30 US disclosed